August 10, 2026
PRIME Scheme and the SME Gap: What July 2026’s Outcomes Reveal
The European Medicines Agency published its latest recommendations on PRIME scheme SME eligibility…
August 3, 2026
EMA-EFPIA Ninth Bilateral Meeting: Europe’s Pharmaceutical Access Crisis and the Road to Reform
On 16 September 2026, the European Medicines Agency (EMA) and the European Federation…
July 27, 2026
MFN Pricing Readiness When Patients Pay for Delay
Most Favoured Nation rules often centre on rebates and reference pricing, yet patients…
July 20, 2026
Oncology Market Access Shapes Sustainable European Innovation
Oncology market access in Europe now demands a more strategic lens. Recent reflections…
July 13, 2026
HTA Regulation SMEs Demand Smarter Market Access Planning
Among SMEs, the HTA Regulation alters how evidence reaches decision makers and shapes…
July 6, 2026
G7 Pharma Strategy and Long-Term Value Assessment
Recent commentary on G7 Pharma Strategy highlights how leading economies can either sustain…